← Back to Search

Behavioural Intervention

Hip activation + Single leg balance for Patellofemoral Pain Syndrome

N/A
Waitlist Available
Led By Erin McCallister, DPT
Research Sponsored by Louisiana State University Health Sciences Center Shreveport
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (8 weeks)
Awards & highlights

Study Summary

This trial aims to see if doing a hip activation exercise program alone is as effective as doing a hip activation exercise program combined with single-leg balance exercises in improving performance on the Forward-Step-Down Test

Who is the study for?
This trial is for healthy female students in their first or second year at the institution's School of Allied Health Professions. They should not be involved in another research study, have current knee pain or issues with their dominant leg, a known balance disorder (vestibular impairment), or be pregnant.Check my eligibility
What is being tested?
The study is testing two types of home exercise programs: one that focuses on hip activation only and another that combines hip activation with single-leg balance exercises. Participants will perform these exercises for 8 weeks to see how they affect performance on the Forward-Step-Down Test.See study design
What are the potential side effects?
Since this trial involves non-invasive physical exercises, side effects may include muscle soreness or fatigue due to the activities. There are no significant medical risks associated with the interventions being tested.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Forward-Step-Down Test
Secondary outcome measures
Dose-Response
Unipedal Stance Test (UPST)
surface electromyography (sEMG) mean
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Hip activation + Single leg balanceExperimental Treatment1 Intervention
Participants will perform a hip muscle activation program as in the active comparator group, plus a single leg balance training HEP 2 days per week for 8 weeks. The hip HEP consists of 5 exercises that target the gluteal muscles. The single leg balance HEP consists of a variety of eyes open and eyes closed single leg balance exercises.
Group II: Hip activationActive Control1 Intervention
Participants will perform a hip muscle activation program 2 days per week for 8 weeks. The HEP consists of 5 exercises that target the gluteal muscles.

Find a Location

Who is running the clinical trial?

Louisiana State University Health Sciences Center ShreveportLead Sponsor
45 Previous Clinical Trials
17,185 Total Patients Enrolled
Erin McCallister, DPTPrincipal InvestigatorLSUHSC-Shreveport
2 Previous Clinical Trials
22 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of individuals participating in this clinical study?

"Indeed, the information available on clinicaltrials.gov indicates that this particular trial is actively seeking participants. The study was initially posted on January 12th, 2024, and subsequently revised on March 1st, 2024. Recruitment targets include enrolling a total of 34 patients at a single designated site."

Answered by AI

Are participants still being enrolled for this ongoing medical study?

"As per clinicaltrials.gov, this investigation is actively seeking eligible participants. The study was initially published on January 12th, 2024 and most recently revised on March 1st, 2024."

Answered by AI

Is the age limit for participants in this trial set at 60 years or above?

"The eligibility criteria for this study state that candidates aged between 18 and 65 are eligible. It is noteworthy that there are separate clinical trials available specifically for individuals under 18 years old as well as those over 65."

Answered by AI
~23 spots leftby May 2025